Crescent Biopharma Inc. (CBIO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Crescent Biopharma Inc.

    NASDAQ: CBIO · Real-Time Price · USD
    12.41
    -0.57 (-4.39%)
    At close: Sep 25, 2025, 3:59 PM
    12.40
    -0.08%
    After-hours: Sep 25, 2025, 07:31 PM EDT

    Crescent Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 10K 75K 1.16M
    Cost of Revenue
    		 35.17K n/a n/a n/a
    Gross Profit
    		 -35.17K 10K 75K 1.16M
    Operating Income
    		 -32.51M -39.28M -47.4M -63.45M
    Interest Income
    		 935.27K 2.38M 714.52K 19.77K
    Pretax Income
    		 -37.88M -36.9M -46.69M -63.43M
    Net Income
    		 -37.88M -36.9M -46.69M -63.43M
    Selling & General & Admin
    		 18.25M 19.21M 19.09M 17.12M
    Research & Development
    		 14.26M 20.07M 28.39M 47.49M
    Other Expenses
    		 -34.86K 637.00 443.00 n/a
    Operating Expenses
    		 32.47M 39.29M 47.48M 64.61M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 32.51M 39.29M 47.48M 64.61M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 64.48M 63.34M 52.53M 51.45M
    Shares Outstanding (Diluted)
    		 64.48M 63.34M 52.53M 51.45M
    EPS (Basic)
    		 -0.59 -0.58 -0.89 -1.23
    EPS (Diluted)
    		 -0.59 -0.58 -0.89 -1.23
    EBITDA
    		 -37.84M -39.12M -47.2M -63.18M
    EBIT
    		 -37.88M -39.27M -47.4M -63.45M
    Depreciation & Amortization
    		 35.17K 153.3K 207.15K 264.6K

    Add to Watchlist